Institutional Equity Research for Undercovered Public Companies
Alliance Equity Research publishes independent and company-sponsored research on undercovered, emerging, and high-potential public companies globally.
Search AER-covered companies and Insights, or explore listed companies across global markets.
Latest Research
Recent initiation reports, research updates and company commentary from Alliance Equity Research.
ASML Holding N.V.
ASML
A Near-Monopoly Lithography Franchise Powering Global Semiconductor Supply Chain with EUV Dominance and High-NA Optionality
Initiation coverage examining EUV leadership, High-NA optionality, DUV economics, installed-base services, competitive moat, semiconductor demand drivers, valuation summary, and key risks.
Dexcom, Inc.
DXCM
Dominant CGM Franchise Leveraging Technology, Coverage Expansion, and Consumer Tailwinds to Sustain Multi-Year Growth
Initiation coverage examining CGM market leadership, product strategy, reimbursement expansion, recurring sensor economics, international growth, valuation summary, and key risks.
Insights
Timely analysis of company developments, industry trends, capital markets activity, and emerging investment themes across global public markets.
Capital Markets & M&ALSEG’s Octus Deal Expands Credit Data at a Price That Requires Sustained Growth
The $3.535 billion acquisition adds recurring revenue from credit research, private loan documents and portfolio tools. LSEG gains a credible route into specialist customer workflows, but debt funding and an initially neutral adjusted earnings contribution leave sustained growth central to the return on its investment.
Mining & Critical MineralsHudbay Approves Copper World as Partner Funding Cushions a Larger Capital Commitment
Copper World’s construction approval gives Hudbay a defined route to a new U.S. mine. Partner capital and planned borrowing defer its cash contributions, but the revised study increases the commitment and makes later expansion spending central to the expected production gains.
Biotechnology & HealthcareHelus Pharma Redesigns Its Anxiety Study as Pivotal Depression Data Approach
Helus is moving HLP004 into a larger, placebo-controlled monotherapy study while its lead depression drug approaches a Phase 3 readout. The revised anxiety program could establish a clearer efficacy signal, but near-term shareholder value depends more heavily on HLP003 and the cost of completing its development.
Biotechnology & HealthcareRoivant’s Uveitis Results Give Brepocitinib a Stronger Route to a Second Market
Two positive Phase 3 studies strengthen the case for expanding brepocitinib beyond its newly approved use in dermatomyositis. Durable disease control after steroid withdrawal supports a commercial opportunity in eye inflammation, although the higher studied dose, safety profile and established alternatives will influence its reach.
Technology & SemiconductorsData I/O’s V-TEK Acquisition Broadens Its Offering but Adds Cash and Dilution Costs
Data I/O’s $23 million acquisition combines chip programming, handling equipment and outsourced services. The commercial fit is credible, but the cash commitment and convertible financing increase the earnings and cash contribution needed to reward shareholders. Disclosed acquired financial information remains insufficient to assess the purchase return.
Mining & Critical MineralsCornish Metals’ £135 Million Raise Would Unlock South Crofty Funding at a Dilutive Price
Cornish Metals has proposed the equity financing needed to advance South Crofty and release its escrowed bond funding. The package also converts shareholder loans and introduces Glencore as a buyer of future production. Existing shareholders gain a clearer construction path while sharing the eventual returns across substantially more shares.
Industrials & AerospaceGE Aerospace Raises Its Outlook as Maintenance Growth Supports Commercial Earnings
GE Aerospace’s higher annual guidance reflects stronger commercial services growth and a smaller expected GE9X earnings impact. Maintenance volume and pricing lifted commercial profit at a broadly stable margin. The remaining cash target implies faster year-over-year growth than GE delivered in the first nine months.
Capital Markets & M&ASilgan’s Trivium Deal Pairs a Cash Release With a Demanding Synergy Plan
Silgan’s proposed Trivium combination would release $2.3 billion in cash and preserve majority ownership of an enlarged metal-packaging business. Its $225 million savings target represents approximately 24% of combined pre-synergy adjusted EBITDA, making integration central to the economics and the intended eventual separation.
Explore Coverage
AER-covered companies combine public-company information with our proprietary research, updates, and commentary.
Find AER-Covered Companies
Explore AER-covered companies by sector, region, and market capitalization.
Research Built Around the Model
Alliance Equity Research develops written company analysis and detailed financial models together. The model is used to test operating assumptions, financial outcomes, scenarios, and valuation frameworks.
- Fundamental company analysis
- Integrated financial modeling
- Scenario-based valuation framework
- Ongoing coverage after initiation
Operating Drivers
RevenuePricingVolumeKPIsFinancial Forecast
Illustrative forecast structure, without financial values Metric FY1 FY2 FY3 FY4 Revenue Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder EBITDA Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder FCF Forecast output placeholder Forecast output placeholder Forecast output placeholder Forecast output placeholder Scenarios & Sensitivities
BaseUpsideDownsideValuation
DCF · Trading Multiples
Published Research
Is Your Company Undercovered?
Alliance Equity Research works with listed companies, recently listed companies, and businesses preparing to list, with a focus on undercovered, emerging, and high-potential opportunities. Our coverage includes initiation research, detailed financial modeling, and ongoing research updates.
- Initiation Research
- Financial Model
- Ongoing Updates
Investor Discovery
- AER Website
- FactSet
- LSEG Refinitiv
- AlphaSense
- Distribution Partners
Stay Current with AER
Choose the research and Insights updates you want to receive.